Search
Home
Products
Notoginsenoside R1
Notoginsenoside R1 WeChat WhatsApp
Product Name Notoginsenoside R1
Price: $18 / 20mg
Catalog No.: CN08006
CAS No.: 80418-24-2
Molecular Formula: C47H80O18
Molecular Weight: 933.13 g/mol
Purity: >=98%
Type of Compound: Triterpenoids
Physical Desc.: White powder
Source: The roots of Panax notoginseng (Burk.)F.H.Chen
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
SMILES: OC[C@H]1O[C@@H](O[C@H]2C[C@]3(C)[C@@H]([C@@]4([C@@H]2C(C)(C)[C@@H](O)CC4)C)C[C@H]([C@H]2[C@@]3(C)CC[C@@H]2[C@@](O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)(CCC=C(C)C)C)O)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]1OC[C@H]([C@@H]([C@H]1O)O)O
Contact us
First Name:
Last Name:
E-mail:
Question:
Description Notoginsenoside R1, the main bioactive component in panaxnotoginseng, is reported to have some neuronal protective, antihypertensive effects. IC50 value:Target:In vitro:In vivo: Notoginsenoside R1 significantly reduce blood pressure in spontaneously hypertensive rats and induce nitric oxide generation through increasing the phosphorylation of iNOS. Notoginsenoside R1 reduces the caudal blood pressure of spontaneously hypertensive rats through induction of iNOS regulated by long non-coding RNA AK094457 [1]. The mice with notoginsenoside R1 treatment showed significant amelioration in the cognitive function and increased choline acetyl transferase expression, as compared to the vehicle treated mice. Notoginsenoside R1 treatment inhibited Aβ accumulation and increased insulin degrading enzyme expression in both APP/PS1 mice and N2a-APP695sw cells [2]. In Notoginsenoside R1 treated rats, expression of TGF-β1and Smad3 at each time point was down-regulated, with statistical significance(P0.05) compared with that in the NDMA group [3].
Density1.4±0.1 g/cm3
Boiling Point1010.5±65.0 °C at 760 mmHg
Flash Point564.9±34.3 °C
Exact Mass932.534485
PSA298.14000
LogP4.42
Vapour Pressure0.0±0.6 mmHg at 25°C
Storage condition2-8°C